Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
Clinical trial NCT00319969 · COMPLETED
Trial details
- NCT number
- NCT00319969
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2008-07-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.